Clinical Trials Directory

Trials / Completed

CompletedNCT00731042

A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Solventum US LLC · Industry
Sex
Female
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGAvagardTopical solution, 6 mL, 6 applications/day for 14 days.
DRUGPurell Surgical ScrubTopical solution, 4 mL, 6 applications/day for 14 days.

Timeline

Start date
2008-03-01
Primary completion
2008-04-01
Completion
2008-07-01
First posted
2008-08-08
Last updated
2024-12-02
Results posted
2009-06-17

Source: ClinicalTrials.gov record NCT00731042. Inclusion in this directory is not an endorsement.

A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects (NCT00731042) · Clinical Trials Directory